Related Experiment Videos
[Rational therapy of salmonella enteritis]
1Institut für Med. Mikrobiologie und Hygiene, Fakultät für Klinische Medizin Mannheim, Universität Heidelberg.
Leber, Magen, Darm
|March 1, 1994
Summary
Ciprofloxacin effectively treats Salmonella enteritis by reaching intracellular bacteria, unlike other antibiotics. Its high activity and rare resistance make it a recommended choice for Salmonella infections.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Context:
- Salmonella enteritis treatment requires antibiotics with direct antibacterial activity and intracellular penetration.
- Salmonella bacteria invade host cells, necessitating intracellular eradication for effective treatment.
- Many antibiotics fail due to poor host cell penetration, limiting their efficacy against intracellular Salmonella.
Purpose:
- To evaluate ciprofloxacin's efficacy in treating Salmonella enteritis.
- To compare ciprofloxacin's properties with other antibiotics for Salmonella infections.
- To determine the suitability of ciprofloxacin for eradicating intracellular Salmonella.
Summary:
- Ciprofloxacin exhibits high direct antibacterial activity against Salmonella, with rare resistance development.
- Unlike other antibiotics, ciprofloxacin effectively penetrates host cells to target intracellular Salmonella.
- Its pharmacokinetic profile allows high intestinal concentrations, optimizing treatment at the site of infection.
Impact:
- Ciprofloxacin offers a reliable and effective treatment option for Salmonella enteritis.
- Its ability to target intracellular bacteria improves cure rates in acute and chronic cases.
- The low risk of resistance spread makes ciprofloxacin a sustainable therapeutic choice.